Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$123.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 180,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 1,875 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 33,750 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 75,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 258,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | UTENDR | 13,280 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 13, 2025 | PBYI | Puma Biotechnology, INC. | SSELL◷ | 11,610 | $3.40 | $39.5K | -13.3% | Open the original filing on SEC.gov |
| Jun 11, 2025 | PBYI | Puma Biotechnology, INC. | AGRANT | 27,000 | — | — | +45.0% | Open the original filing on SEC.gov |